Biomed Central Ltd

SHERPA: Unknown

People

  1. Budhu
    Budhu
  2. Gupta
    Gupta
  3. Barker
    Barker
  4. Holland
    Holland
  5. Khalil
    Khalil
  6. Liu
    Liu
  7. Mangarin
    Mangarin

Groups

  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Melanoma and Immunotherapeutics Service (7)
  4. Sloan Kettering Institute Postdocs (7)
  5. Solid Tumor Oncology Division (7)
  6. Hematology-Oncology Fellows (4)
  7. GME, Medicine (3)
  8. Graduate Medical Education (3)
  9. MSK Grad Students (2)
  10. Melanoma Disease Management Team (2)
Search Within
  1. "Luis Felipe Ingrassia Campesato"
Formats
  1. Meeting Abstract (7)
Groups
  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Melanoma and Immunotherapeutics Service (7)
  4. Sloan Kettering Institute Postdocs (7)
  5. Solid Tumor Oncology Division (7)
  6. Hematology-Oncology Fellows (4)

More Groups

People
  1. Jedd Wolchok (7)
  2. Luis Felipe Ingrassia Campesato (7)
  3. Taha Merghoub (7)
  4. Sadna Budhu (5)
  5. Aditi Gupta (3)
  6. Rachel Giese (3)

More People

Years
  1. 2021 (1)
  2. 2019 (1)
  3. 2018 (1)
  4. 2017 (3)
  5. 2016 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of stroma poor cancers
    Meeting Abstract

    Budhu, S.; Gupta, A.; Fitzgerald, K.; Giese, R.; Michel, A.; Holland, A.; Campesato, L. F.; Van Snick, J.; Uyttenhove, C.; Ritter, G.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Blockade of IDO/TDO downstream effectors restricts a Treg-macrophage suppressive axis and resistance to anti-PD-1 therapy
    Meeting Abstract

    Campesato, L.; Budhu, S.; Tchaicha, J.; Gigoux, M.; Cohen, I.; Mangarin, L.; Redmond, D.; Pourpe, S.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Targeting phosphatidylserine enhances the anti-tumor response to radiation therapy and immune checkpoint blockade in a preclinical melanoma model
    Meeting Abstract

    Budhu, S.; Giese, R.; Gupta, A.; Schad, S.; De Henau, O.; Zappasodi, R.; Campesato, L.; Barker, C.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Targeting the IDO/TDO pathway through degradation of the immunosuppressive metabolite kynurenine and inhibition of the downstream AHR pathway
    Meeting Abstract

    McGovern, K.; Zhang, X. M.; Stone, E.; Triplett, T.; Garrison, K.; Coma, S.; Campesato, L. F.; Walsh, M.; Tchaicha, J.; Lamb, C.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Meeting Abstract

    Budhu, S.; Giese, R.; De Henau, O.; Zappasodi, R.; Campesato, L. F.; Gupta, A.; Barker, C.; Freimark, B.; Wolchok, J. D.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Investigating the kynurenine pathway as a central effector mechanism of tumor immune-suppression and its potential as therapeutic target
    Meeting Abstract

    Campesato, L. F.; Budhu, S.; Zhang, X. M.; Manfredi, M. G.; McGovern, K.; Wolchok, J. D.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Local intratumoral treatment with low-dose CD40 and TLR4 agonists overcomes resistance to PD-1 blockade to control tumors systemically
    Meeting Abstract

    Khalil, D. N.; Campesato, L. F.; Li, Y.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save